HTFLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Heartflow, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$51.02+2.73 (+5.65%)
Close on Oct 19, 2026
- Market cap
- $4.41B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$17.25 (+51.08%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Heartflow, Inc. grew revenue 42.8% to $212.08M over the twelve months to Jun 30, 2026. Free cash flow was -$59.18M.
Revenue
$212.08M
+42.8% vs. a year earlier
Operating income
-$80.25M
TTM Q2 2026
Free cash flow
-$59.18M
TTM Q2 2026
EPS, diluted
-$3.17
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $4.41B
- P/E ratio
- –
- Price to sales
- 20.79
- Price to book
- 15.76
- Dividend yield
- –
- Free cash flow yield
- -1.34%
Fundamentals
- Revenue
- $212.08M
- Net income
- -$118.37M
- EPS, diluted
- -$3.17
- Free cash flow
- -$59.18M
- Book value per share
- $3.24
- Diluted shares
- 86M
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
$212.08M+42.8% YoY
Gross profit
$169.83M+51.8% YoY
Operating income
-$80.25M
Net income
-$118.37M
EPS, diluted
–
Free cash flow
-$59.18M
Reported periodTrailing twelve months